ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03259633
Brief Title: An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

First Submitted : August 21, 2017
First Submitted that Met QC Criteria : August 21, 2017
First Posted : August 24, 2017

Last Update Submitted that Met QC Criteria : November 8, 2018
Last Update Posted : November 9, 2018